Millennials are on the verge of costing healthcare billions

WHY? According to the Lancet “cancer trends in young adults, often under 50 years, reflect recent changes in carcinogenic exposures, which could foreshadow the future overall disease burden. The risk of developing obesity-related cancer seems to be increasing in a stepwise manner in successively younger birth cohorts in the USA.

Continue reading

Prescription drug prices are out of control (Here’s why)

SUMMARY: According to a new report from the Institute for Clinical and Economic Review released on Tuesday, combined price hikes from seven drugs, in 2017 and 2018, contributed to a $5.1 billion increase in U.S. spending. None of those drugs had new important evidence to support the price increase, the study concluded. Why is this happening?

Continue reading